LLY News and Press, Eli Lilly and Company From 01/10/24

2024-01-10 12:09:02 ET More on Regeneron Pharmaceuticals Regeneron Pharmaceuticals Inc. (REGN) 42nd Annual JPMorgan Healthcare Conference - (Transcript) Why I Expect Regeneron To Keep Delivering For Investors In 2024 (Upgrade) Regeneron Pharmaceuticals Inc. (REGN) Am...

2024-01-10 08:30:36 ET NetworkNewsWire Editorial Coverage New York, NY – January 10, 2024 – On Sept. 20, 2019, history was made when the U.S. Food and Drug Administration approved Rybelsus as the first oral glucagon-like peptide-1 (GLP-1) agonist for type 2 dia...

2024-01-10 05:51:00 ET Skyrocketing 59%. Reaching a market cap of over $550 billion. Vaulting past Johnson & Johnson to become the biggest pharmaceutical company on the planet. No matter how you look at it, 2023 was a pivotal year for Eli Lilly (NYSE: LLY) . It might see...

2024-01-09 21:35:22 ET Eli Lilly and Company (LLY) JPMorgan 42nd Annual Healthcare Conference January 9, 2024 16:15 ET CorporateParticipants Dave Ricks - Chairman and Chief Executive Officer ConferenceCall Participants Chris Schott - JPMorgan Presentati...

2024-01-09 14:52:04 ET Shares of contract manufacturer Catalent ( NYSE: CTLT ) traded higher on Tuesday to reach the highest level in more than four months after its CEO, Alessandro Maselli, highlighted the company’s production capacity related to GLP-1 class of weight loss d...

2024-01-09 11:40:35 ET More on Madrigal, Viking, etc. Madrigal Pharmaceuticals: A Deeper Look At A Looming NASH Play Viking: Results From 2 Clinical Trials Of Weight Loss Drug Ahead, Other Catalysts On Tap Madrigal Pharmaceuticals: Preparing For Resmetirom's Commerci...

2024-01-08 14:07:33 ET More on Eli Lilly Profiting From Obesity Drugs HRTS, Novo Nordisk And Eli Lilly Eli Lilly: Consider Cutting Before The Southbound Train Leaves (Rating Downgrade) Eli Lilly: Long Path To A Trillion Alphabet unit inks deals with Eli Lilly...

2024-01-08 12:53:29 ET Summary Large pharma stocks, including Johnson & Johnson, may be experiencing a shift in favor as investors move away from glamour growth stocks as 2024 gets underway. Johnson & Johnson is a leading global healthcare company with a below-market valua...

2024-01-08 11:19:33 ET More on Alphabet Google: Don't Be Too Late To The Party! Google: It Warrants A Large Allocation Google: Time To Load Up (Upgrade) Apple, Alphabet, Broadcom, Nvidia CEOs to meet with EU antitrust chief next week Pinterest and Sna...

2024-01-08 08:31:52 ET Summary The healthcare sector was flat in 2023 year as a result of some unique issues. Drug price regulation will be a serious challenge for the sector this year. Defensive healthcare industry groups should do well during the first half and biotechnology...